Acid phosphatase activity in the blood serum is usually separated into tartrate-resistant and tartrate-refractory, which is reported as the prostatic acid phosphatase level. Human prostatic acid phosphatase crystals soaked in N-propyl-L-tartramate were used to collect x-ray diffraction data to 2.9 Å resolution under cryogenic conditions. Positive difference electron density, corresponding to the inhibitor, was found. The quality of the electron density maps clearly shows the orientation of the carboxylate and N-propyl-substituted amide groups. The hydroxyl group attached to C3 forms two crucial hydrogen bonds with Arg-79 and His-257. Previous crystallographic studies compiled on the tartrate-rat prostatic acid phosphatase binary complex (Lindqvist, Y., Schneider, G., and Vihko, P. Human prostatic acid phosphatase (PAP) 1 has been of significant medical interest ever since tests screening for serum PAP levels were successfully used to diagnose and stage prostate cancer (1). Recently, the primary diagnostic protocol for detecting prostate cancer has shifted from evaluating serum PAP levels to utilizing the prostate specific antigen test. However, accurately detecting serum PAP levels is still of considerable interest because of its effectiveness in staging metastatic prostatic cancer and evaluating the progress of chemotherapy in prostate cancer patients (2).PAP, which is produced by the prostate gland, is found in the seminal fluid at concentrations near 1 mg/ml (3). The enzyme is categorized as an acid phosphatase, because its optimum pH range is between 4 and 7. PAP belongs to the family of high molecular weight phosphatases. Mature PAP is active as a glycosylated homodimer with M r ϭ ϳ100,000. The enzyme is capable of hydrolyzing a wide spectrum of substrates including alkyl, aryl, and acyl orthophosphate monoesters and phosphorylated proteins (4). The natural substrate for PAP is uncertain, thus, the discovery of the specific biological function is of great interest and awaits further investigations.The catalytic mechanism has been intensely studied and it was concluded that the enzyme should be classified as a histidine phosphatase (5). The crucial intermediate is phosphoroamidate, namely phosphohistidine. The rate-limiting step is the breakdown of this covalent phosphoenzyme intermediate through addition of a nucleophilic water molecule to phosphoroamidate with concomitant elimination of inorganic phosphate, via a S N 2 mechanism, to form a noncovalent binary enzyme-inorganic phosphate complex. Extensive studies of chemically modified enzyme and a series of site-directed mutants allowed Van Etten and co-workers (5) to propose a sound description of the catalytic process.L(ϩ)-Tartrate is a fairly good inhibitor of PAP (K i ϭ 2.9 ϫ 10 Ϫ5 M at pH 5.0). It is specific for acid phosphatases; in addition to PAP, it also inhibits homologous lysosomal acid phosphatases and acid phosphatases isolated from such tissues as liver, bone, and kidney, which are usually not present in the blood serum (6). The inhibition is...